Morning Briefing
Summaries of health policy coverage from major news organizations
Despite Mounting Health Concerns Over Pesticide, EPA Chief Rejects Ban On Chemical
Scott Pruitt, the head of the Environmental Protection Agency, moved late on Wednesday to reject the scientific conclusion of the agency鈥檚 own chemical safety experts who under the Obama administration recommended that one of the nation鈥檚 most widely used insecticides be permanently banned at farms nationwide because of the harm it potentially causes children and farm workers. (Lipton, 3/29)
The chemical compound chlorpyrifos, also known as Lorsban, has been used by farmers for more than a half-century to kill pests on crops聽including broccoli,聽strawberries and聽citrus. The EPA banned its spraying indoors to combat household bugs聽more than a decade ago. But only in recent years did the agency seek to ban its use in agriculture, after mounting scientific evidence that prenatal exposure can pose risks to fetal brain and nervous system development. (Dennis, 3/29)
In other administration news聽鈥
Medical research can鈥檛 be done in the dark. But should taxpayers be covering the light bills at university labs across the country? The Trump administration鈥檚 answer is no. The president has proposed a massive $7 billion budget cut for the National Institutes of Health over the next 18 months. And Secretary of Health and Human Services Tom Price said this week that he may find those savings in the 鈥渋ndirect expenses鈥 that NIH funds, which includes everything from buying lab equipment聽to paying the electric bills for thousands聽of academic research labs from Harvard to Ohio State to Stanford. (Keshavan, 3/31)
From research on stem cells and DNA sequencing to experiments with fruit flies and surveys of human behavior, projects funded by the National Institutes of Health aim to make Americans healthier. A new analysis finds that NIH-funded research also fuels the kinds of innovations that drive the U.S. economy. Between 1990 and 2012, close to 1 in 10 projects made possible by an NIH grant resulted in a patent, usually for a university or a hospital. (Healy, 3/30)